151 related articles for article (PubMed ID: 28453459)
21. [Concurrent chemoradiotherapy followed by consolidation chemotherapy and sequential chemoradiotherapy for stage III non-small cell lung cancer: comparison in 93 patients].
Sun WZ; Song LP; Zhang YB; Ai T; Lu JL; Ren J; Gao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):362-7. PubMed ID: 22445984
[TBL] [Abstract][Full Text] [Related]
22. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
23. The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC).
Men Y; Luo Y; Zhai Y; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Hui Z; Wang L
Oncotarget; 2017 Jul; 8(30):48922-48929. PubMed ID: 28430661
[TBL] [Abstract][Full Text] [Related]
24. Thoracic Surgery in Early-Stage Small Cell Lung Cancer.
Low M; Ben-Or S
Thorac Surg Clin; 2018 Feb; 28(1):9-14. PubMed ID: 29150041
[TBL] [Abstract][Full Text] [Related]
25. The revision of 8th edition TNM stage criteria is more accurate in prediction postoperative survival for SCLC patients.
Li J; Zhao Y; Li C; Zhu L; Liu C; Liu L
Int J Surg; 2017 Dec; 48():83-85. PubMed ID: 28987562
[TBL] [Abstract][Full Text] [Related]
26. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR
J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
29. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K
Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447
[TBL] [Abstract][Full Text] [Related]
30. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
31. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):538-46. PubMed ID: 21684554
[TBL] [Abstract][Full Text] [Related]
32. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of effectiveness and safety of different treatment modes for limited-stage small cell lung].
Shen J; Wang LH; Zhang FQ; Wang MZ; Li Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):343-7. PubMed ID: 23827076
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer.
Stish BJ; Hallemeier CL; Olivier KR; Harmsen WS; Allen MS; Garces YI
Clin Lung Cancer; 2015 Sep; 16(5):e67-73. PubMed ID: 25823413
[TBL] [Abstract][Full Text] [Related]
35. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?
Gong L; Wang QI; Zhao L; Yuan Z; Li R; Wang P
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):196-200. PubMed ID: 22818415
[TBL] [Abstract][Full Text] [Related]
37. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
38. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of postoperative unsuspected small cell lung cancer on real-world data.
Guo J; Shen L; Ren Z; Liu Y; Liang C
BMC Cancer; 2022 Dec; 22(1):1256. PubMed ID: 36461029
[TBL] [Abstract][Full Text] [Related]
40. [Combined-modality therapy for lung cancer].
Miura S; Yamamoto N
Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
